|
Volumn 35, Issue 4, 2003, Pages 1265-1270
|
Diabetes mellitus in transplantation: 2002 Consensus guidelines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACARBOSE;
ALPHA GLUCOSIDASE INHIBITOR;
ANTIDIABETIC AGENT;
AZATHIOPRINE;
BASILIXIMAB;
BIGUANIDE;
CALCINEURIN INHIBITOR;
CORTICOSTEROID;
CYCLOSPORIN;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
METFORMIN;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISONE;
RAPAMYCIN;
STEROID;
SULFONYLUREA;
TACROLIMUS;
THIAZOLIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL EXAMINATION;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
DEATH;
DIABETES MELLITUS;
ETHNOLOGY;
FAMILY HISTORY;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN TREATMENT;
ORAL GLUCOSE TOLERANCE TEST;
ORGAN TRANSPLANTATION;
PANCREAS DISEASE;
PATIENT CARE;
PATIENT COUNSELING;
PATIENT MONITORING;
POSTOPERATIVE CARE;
POSTOPERATIVE COMPLICATION;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
RISK FACTOR;
SCREENING;
SELF MONITORING;
SURGICAL MORTALITY;
SURGICAL PATIENT;
|
EID: 0037783800
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(03)00434-2 Document Type: Conference Paper |
Times cited : (31)
|
References (20)
|